Abstract
Neck mass is a common clinical finding in all age groups. Although most neck masses have the nature of benign processes, malignant diseases must ruled out. Careful medical history, such as the duration of the mass, the presence of pain, history of upper airway infection, contact history of animals, and travel, should be obtained. Thorough physical examination should be also performed. The patients' age and the location, size, and duration of the neck masses are important pieces of information. Neck masses in children (0 to 15 years) are more commonly inflammatory than congenital or developmental and those in young adult (16∼40 years) are more commonly congenital than neoplastic. However, the first consideration in elderly adults (>40 years) should be neoplasia. The location of the mass is particularly important with respect to the differentiation between congenital and developmental masses because such lesions are consistent in their location. For metastatic neck masses, their location may be the key to the identification of the primary tumor. Inflammatory and infectious causes of neck masses, such as cervical adenitis and cat?scratch disease, are common in young adults. The progressively increasing size of the mass indicates malignancy, however, a rapid change of size usually suggests an infectious mass. Congenital masses, such as branchial anomalies and thyroglossal duct cysts, should be considered in the differential diagnosis. Neoplasms (benign and malignant) are more likely to be present in older adults. Ultrasonography-guided biopsy is the best diagnostic method for evaluating neck masses. Panendoscopy (nasopharyx, palatine tonsil, base of tongue, piriform sinus, esophagus, stomach, trachea, and lungs) must be performed in all patients of malignant disease. The Open biopsy should be performed only in case of the neck masses which persist beyond four to six weeks after a single course of a broad-spectrum antibiotic or suspects the malignat lymphoma.
References
1. McGuirt WF. Differential diagnosis of neck masses. Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE, editors. Otolaryngology?Head and Neck Surgery. 4th ed.St. Louis: Mosby Year Book;2006. p. 2540–2553.
2. Robbins KT, Samant S. Neck dissection. Cummings CW, Flint PW, Harker LA, Haughey BH, Richardson MA, Robbins KT, Schuller DE, Thomas JR, editors. Otolaryngology?Head and Neck Surgery. 4th ed.St. Louis: Mosby Year Book;2006. p. 2614–2645.
3. Weber RS, Byers RM, Petit B, Wolf P, Ang K, Luna M. Submandibular gland tumors. Adverse histologic factors and therapeutic implications. Arch Otolaryngol Head and neck Surg. 1990; 116:1050–1060.
4. Skandalakis JE, Gray SW, Takakis NC. Tumors of the neck. Surgery. 1960; 48:375–384.
5. Mancuso AA, Harnsberger HR, Muraki AS. Computed tomography of cervical and retropharyngeal lymph nodes: Normal anatomy, variants of normal and applications in staging head and neck cancer. Part II: Pathology. Radiology. 1983; 148:715–723.
6. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. Am J Radiol. 1992; 158:961–969.
7. Bhattacharyya N. Predictive factors for neoplasia and malignancy in a neck mass. Arch Otolaryngol Head Neck Surg. 1999; 125:303–307.
8. DeVita VT Jr, Jaffe ES, Hellman S. Hodgkin's disease and the non?Hodgkin's lymphomas. DeVita VT, Hellman S, Rosenberg SA, editors. Cancer. Principles and Practice of Oncology. 2nd ed.Philadelphia: JB Lippincott Co;2006. p. 1623–1710.
9. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. Am J Radiol. 1992; 158:961–969.
10. Yousem DM, Hatabu H, Hurst RW, Seigerman HM, Montone KT, Weinstein GS, Hayden RE, Goldberg AN, Bigelow DC, Kotapka MJ. Carotid artery invasion by head and neck mass: prediction with MR imaging. Radiology. 1995; 195:715–727.
11. Carter RL, Barr LC, Orien CJ, Soo KC, Shaw HJ. Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg. 1985; 150:495–499.
12. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Maxillofac Surg. 2000; 28:319–324.
13. Lindholm P, Minn H, Leskinen?Kallion S, Bergman J, Ruotsalainen U, Joensuu H. Infulence of the blood glucose concentration on FDG uptake in cancer?a PET study. J nucl Med. 1993; 34:1–6.
14. Hautzel H, Muller?Gartner HW. Early changes in fluorine?18? FDG uptake during radiotherapy. J nucl Med. 1997; 38:1384–1384.
15. Zimmer LA, McCook B, Meltzer C, Fukui M, Bascom D, Sny-derman C, Townsend DW, Johnson JT. Combined positron emission tomography/computed tomography imaging of recur-rentthyroid cancer. Otolaryngol Head Neck Surg. 2003; 128:178–184.
16. McGuirt WF, McCabe BF. Significance of node biopsy before definitive treatment of cervical metastatic carcinoma. Laryngoscope. 1978; 88:594–597.
17. Medina JE. Neck dissection. In: Bailey BJ, Head & Neck Surgery?Otolaryngology. 2nd ed.Philadelphia: Lippincott? Raven;1998. p. 1587.
18. Knight PJ, Mulne AF, Vassy LE. When is lymph node biopsy indicated in children with enlarged peripheral nodes? Pediatrics. 1982; 69:391–396.
19. Knight PJ, Reiner CB. Superficial lumps in children: What, When, and Why ? Pediatrics. 1983; 72:147–153.
20. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debri and phagocytosis. Acta Haematol JPN. 1972; 35:379–380.
21. Lin HC, Su CY, Huang CC, Hwang CF, Chien CY. Kikuchi's disease: A review and analysis of 61 cases. Otolaryngol Head Neck Surg. 2003; 128:650–653.
22. Lerosey Y, Lecler?Scarcella V, Francois A, Guitrancourt JA. A pseudotumoral form of Kikuchi's disease in children: A case report and review of the litera?ture. Int J pediatr Otorhinolaryngol. 1998; 45:1–6.
23. Kim JY, Suh KS, Kim YK. Diagnosis and management of tuberculous cervical lymphadenitis. Korean J Otolaryngol. 1995; 38:275–280.
24. Day TA, Joe JK. Primary neoplasms of the neck. Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE, editors. Otolaryngology?Head and Neck Surgery. 3rd ed.St. Louis: Mosby Year Book;2006. p. 2554–2576.
25. DeLacure MD, Lee KJ. Carotid body tumors, vascular anomalies, melanoma, cyst and tumors of the jaws. In: Lee KJ, Essential Otolaryngology. 6th ed.Appleton & Lange: 2006. p. 611–617.
26. Edgerton MT. The treatment of hemangiomas: With special reference to the role of steroid therapy. Ann Surg. 1976; 183:517–530.
27. Jackson IT, Carreno R, Potparic Z. Hemangiomas, vascular malformations and lymphovenous malformations: Classification and methods of treatment. Plast Reconstr Surg. 1993; 92:1216–1230.
28. Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg. 1982; 70:120–121.
29. Hodge KT, Byers RM, Peters LJ. Paragangliomas of the head and neck Arch Otolaryngol Head Neck Surg. 1998; 114:872–877.
30. Weymuller EA Jr, Kiviat NB, Duckett LG. Aspiration cytology and cost effective modalty. Laryngoscope. 1983; 93:561–564.
31. Silver CE, Rubin JS. Cysts and primary tumors of head and neck. In: Silver CE, Rubin JS, eds. Atlas of Head and Neck Surgery, 2nd ed. Churchill Livingstone. 2006. 1–25.
32. Strasinger SK. Miscellaneous body fluids. Urinalysis and body fluids. 3rd ed.Philadelphia: F. A. Davis Company;2006. p. 159–203.
33. Brewis C, Pracy JP, Albert DM. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK?432 (Picibanil). Clin Otolaryngol. 2000; 25:130–134.
34. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 1995; 30:1282–1287.
35. Jaber MR, Goldsmith AJ. Sternocleidomastoid tumor of infancy: two cases of an interesting entity. Int J Pediatr Otorhi? nolaryngol. 1999; 47:269–274.
36. Bedi DG, John SD, Swischuk LE. Fibromatosis colli of infancy: variability of sonographic appearance. J Clin Ultrasound. 1998; 26:345–348.
37. Myssiorek D, Persky M, Laser endoscop [ic treatment of laryngocele and laryngeal cysts. Otolaryngol Head Neck surg. 1989; 100:538–541.
38. Booth JB, Brick HG, Operative treatment and postoperative management of saccule cyst and laryngocele. Arch Otolaryngol. 1981; 107:500–502.
39. Close LG, Merkel M, Burns DK, Deaton CW, Schaefer SD. Asymptomatic laryngocele: Incidence and association with laryngeal cancer. Ann Otol Rhinol Laryngol. 1997; 96:393–399.
40. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956; 9:822–830.
41. McAdams HP, Rosado?de?Christenson M, Fishback NF, Templeton PA. Castleman disease of the thorax: Radiologic features with clinical and histopathologic correlation. Radiology. 1998; 209:221–218.
42. Keller AR, Hochholzer L, Castleman B. Hyaline?vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29:670–683.
43. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Brennan MF, Brennan MF. The management of unicentric and multi?centric Castleman's disease: A report of 16 cases and a review of the literature. Cancer. 1999; 85:706–717.
Table 1.
0~15 | 16~40 | 40+ |
---|---|---|
Inflammatory ↓ |
Inflammatory ↓ |
Neoplasia ↓ |
Congenital ↓ |
Congenital ↓ |
Inflammatory ↓ |
Neoplasia ↓ |
Neoplasia ↓ |
Congenital ↓ |
Traumatic | Traumatic | Traumatic |